Bolt Biotherapeutics, Inc. Quarterly Operating Margin in % from Q4 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q2 2024.
  • Bolt Biotherapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -695 %, a 42.2% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Operating Margin for 2023 was -967 %, a 38.6% increase from 2022.
  • Bolt Biotherapeutics, Inc. annual Operating Margin for 2022 was -1.58K %, a 78.6% increase from 2021.
  • Bolt Biotherapeutics, Inc. annual Operating Margin for 2021 was -7.36K %, a 65.4% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -695 +508 +42.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -661 +597 +47.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -967 +609 +38.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.08K Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.2K Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.26K Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.58K Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.